4.6 Article

In Vivo Kinetics and Biotransformation of Aflatoxin B1 in Dairy Cows Based on the Establishment of a Reliable UHPLC-MS/MS Method

Journal

FRONTIERS IN CHEMISTRY
Volume 9, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fchem.2021.809480

Keywords

aflatoxins; in vivo kinetics; biotransformation; dairy cow; UHPLC-MS; MS

Funding

  1. National Key RD Plan [2017YFC1700806]
  2. Shanghai Rising-Star Program [21QB1403300]
  3. Science and Technology Innovation Action Plan Project of Shanghai Municipal Commission of Science and Technology [17391901200]
  4. National Natural Science Foundation of China [31972178]

Ask authors/readers for more resources

By studying the in vivo kinetics and biotransformation of AFB(1) in dairy cows, it was found that AFB(1) transformed into AFM(1) within 48 hours, and the clearance period of AFM(1) in milk was no more than 2 days. The carry-over rate of AFM(1) in milk during continuous ingestion experiments was around 1.15-2.30%.
The in vivo kinetics of aflatoxin B-1 (AFB(1)) and its carry-over as aflatoxin M-1 (AFM(1)) in milk as well as the toxin loads in the tissue of dairy cows were assessed through a repetitive feeding trial of an AFB(1)-contaminated diet of 4 mu g kg(-1) body weight (b.w.) for 13 days. This was followed by a clearance period that ended with a single dose trial of an AFB(1)-contaminated diet of 40 mu g kg(-1) b.w. An ultra-high performance liquid chromatography tandem mass spectrometry method was developed and successfully validated by the determination of linearity (R-2 >= 0.990), sensitivity (lower limit of quantification, 0.1-0.2 ng ml(-1)), recovery (79.5-111.2%), and precision relative standard deviation (RSD) <= 14.7%) in plasma, milk, and various tissues. The repetitive ingestion of AFB(1) indicated that the biotransformation of AFB(1) to AFM(1) occurred within 48 h, and the clearance period of AFM(1) in milk was not more than 2 days. The carry-over rate of AFM(1) in milk during the continuous ingestion experiment was in the range of 1.15-2.30% at a steady state. The in vivo kinetic results indicated that AFB(1) reached a maximum concentration of 3.8 +/- 0.9 ng ml(-1) within 35.0 +/- 10.2 min and was slowly eliminated from the plasma, with a half-life time (T-1/2) of 931.1 +/- 30.8 min. Meanwhile, AFM(1) reached a plateau in plasma (0.5 +/- 0.1 ng ml(-1)) at 4 h after the ingestion. AFB(1) was found in the heart, spleen, lungs, and kidneys at concentrations of 1.6 +/- 0.3, 4.1 +/- 1.2, 3.3 +/- 0.9 and 5.6 +/- 1.4 mu g kg(-1), respectively. AFM(1) was observed in the spleen and kidneys at concentrations of only 0.7 +/- 0.2 and 0.8 +/- 0.1 mu g kg(-1), respectively. In conclusion, the in vivo kinetics and biotransformation of AFB(1) in dairy cows were determined using the developed UHPLC-MS/MS method, and the present findings could be helpful in assessing the health risks to consumers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available